The relationship between heart functions and anemia in patients with end-stage renal disease receiving hemodialysis
Abstract
Objective: We investigated the relationship between anemia and cardiac functions by conventional and speckle-tracking echocardiography (STE) in patients with end-stage renal disease (ESRD) receiving hemodialysis.
Methods: One hundred six patients with ESRD receiving hemodialysis were included in this cross-sectional study. The conventional echocardiography and STE findings were compared between the patients with and without anemia. In addition, a comparison of the findings between the ESRD patients and healthy controls consisting of 68 participants was conducted.
Results: Compared to healthy controls, ESRD patients had lower left ventricular ejection fraction (LVEF), left ventricular global longitudinal strain (LVGLS), and left atrial reservoir strain (LASr) [53% (48-57) vs. 65% (62-68), -15.2 (-16.9˗ -13.6) vs. -19.7 (-16.9˗ -13.6), and -21.9 (-29.5˗ -15.3) vs. -29.9 (-35.3˗ -22.8), respectively, P-value <0.001 for all]. Of the ESRD patients, 70 (66%) had anemia. ESRD patients with anemia had higher interventricular septum (IVS), posterior wall (PW), and left atrial volume index (LAVi) values than patients without anemia. In addition, ESRD patients with anemia had lower LVEF, LVGLS, and LASr than patients without anemia [median (IQR), 13 (12-15) vs. 12 (11-14), P=0.004, 13 (12-15) vs. 12 (11-13.5), P<0.005, 43 (35-55) vs. 34.7 (28-50), P=0.013, 52 (48-55) vs. 56 (47.5-60), P=0.016, -14.6 (-16.4˗ -13.5) vs. -16 (-18.6˗ -14.7), P=0.003, and -21.6 (-30.5˗ -16.3) vs. -30.5 (-33.6˗ -23.3), P=0.006, respectively]. In multivariable logistic regression analysis, diabetes, PW, LASr, and LVGLS were independently associated with the presence of anemia in ESRD patients.
Conclusion: Our study confirmed impaired cardiac mechanics in ESRD hemodialysis patients and showed that anemia was associated with further worsening cardiac mechanics in this population.
Keywords
References
- 1. Thurlow JS, Joshi M, Yan G, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98-107. doi: 10.1159/000514550.
- 2. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32(5):853-906. doi: 10.1016/s0272-6386(98)70145-3.
- 3. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112-9. doi: 10.1053/ajkd.1998.v32.pm9820470.
- 4. Jankowski J, Floege J, Fliser D, Böhm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686.
- 5. Georgatzakou HT, Antonelou MH, Papassideri IS, Kriebardis AG. Red blood cell abnormalities and the pathogenesis of anemia in end-stage renal disease. Proteomics Clin Appl. 2016;10(8):778-790. doi: 10.1002/prca.201500127.
- 6. Sofue T, Nakagawa N, Kanda E, et al. Prevalence of anemia in patients with chronic kidney disease in Japan: a nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLoS One. 2020;15(7):e0236132. doi: 10.1371/journal.pone.0236132.
- 7. Omrani H, Golshani S, Sharifi V, Almasi A, Sadeghi M. The relationship between hemodialysis and the echocardiographic findings in patients with chronic kidney disease. Med Arch. 2016;70(5):328-331. doi: 10.5455/medarh.2016.70.328-331.
- 8. Parfrey PS, Harnett JD, Barre PE. The natural history of myocardial disease in dialysis patients. J Am Soc Nephrol. 1991;2(1):2-12. doi: 10.1681/ASN.V212.
Details
Primary Language
English
Subjects
Cardiology
Journal Section
Research Article
Authors
Timor Omar
*
0000-0002-2481-0505
Türkiye
Metin Çağdaş
0000-0001-6704-9886
Türkiye
İnanç Artaç
0000-0003-2694-8978
Türkiye
Doğan İliş
0000-0002-1871-5157
Türkiye
Ayça Arslan
0000-0002-9152-1199
Türkiye
Yavuz Karabağ
0000-0002-8156-315X
Türkiye
Mahmut Yesin
0000-0002-2515-1265
Türkiye
Mustafa Avcı
0000-0002-0522-3284
Türkiye
Early Pub Date
December 26, 2023
Publication Date
January 4, 2024
Submission Date
December 7, 2023
Acceptance Date
December 25, 2023
Published in Issue
Year 2024 Volume: 10 Number: 1
Cited By
Investigating the Link Between Left Ventricular Hypertrophy and Anemia in End-Stage Renal Disease
DEVELOPMENTAL MEDICO-LIFE-SCIENCES
https://doi.org/10.69750/dmls.01.03.028